136 related articles for article (PubMed ID: 38281223)
1. The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study.
Zhang ZC; Huang SP; Lin ZS; Chen Y; Jiang P; Yang YW; Shang CJ; Zhu M; Gao HJ
Aging Clin Exp Res; 2024 Jan; 36(1):10. PubMed ID: 38281223
[TBL] [Abstract][Full Text] [Related]
2. Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study.
Xia D; Wang J; Zhao X; Shen T; Ling L; Liang Y
Front Cell Infect Microbiol; 2023; 13():1248381. PubMed ID: 37799337
[TBL] [Abstract][Full Text] [Related]
3. Causal Associations Between Lifestyle Habits and Risk of Benign Prostatic Hyperplasia: A Two-Sample Mendelian Randomization Study.
Jia F; Wei Z; Kong X; Mao Y; Yang Y
J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37526403
[TBL] [Abstract][Full Text] [Related]
4. The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
Lv K; Yang G; Wu Y; Xia X; Hao X; Pang A; Han D; Yuan Q; Song T
Prostate; 2023 Oct; 83(14):1358-1364. PubMed ID: 37455410
[TBL] [Abstract][Full Text] [Related]
5. Causal associations of immune cells with benign prostatic hyperplasia: insights from a Mendelian randomization study.
Li T; Zhang Y; Zhou Z; Zhang Y; Song X; Zhou X; Wan Z; Ruan Y
World J Urol; 2024 Apr; 42(1):216. PubMed ID: 38581575
[TBL] [Abstract][Full Text] [Related]
6. Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia.
Lin L; Wang W; Xiao K; Guo X; Zhou L
J Endocrinol Invest; 2023 Oct; 46(10):2095-2102. PubMed ID: 36913135
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Telomere Length and the Risk of Prostate Cancer and Benign Prostatic Hyperplasia: Insights From UK Biobank and Mendelian Randomization Study.
Lv K; Wu Y; Yang G; Hao X; Huang S; Song T; Yuan Q
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 38085929
[TBL] [Abstract][Full Text] [Related]
8. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.
Wang YB; Yang L; Deng YQ; Yan SY; Luo LS; Chen P; Zeng XT
J Transl Med; 2022 Oct; 20(1):495. PubMed ID: 36309747
[TBL] [Abstract][Full Text] [Related]
9. The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia.
Rao X; Xu Z; Zhang J; Zhou J; Huang J; Toh Z; Zheng R; Zhou Z
Front Endocrinol (Lausanne); 2023; 14():1290639. PubMed ID: 38027182
[TBL] [Abstract][Full Text] [Related]
10. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
11. Genetic susceptibility of benign prostatic hyperplasia.
Sanda MG; Beaty TH; Stutzman RE; Childs B; Walsh PC
J Urol; 1994 Jul; 152(1):115-9. PubMed ID: 7515446
[TBL] [Abstract][Full Text] [Related]
12. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study.
Adams CD; Richmond R; Ferreira DLS; Spiller W; Tan V; Zheng J; Würtz P; Donovan J; Hamdy F; Neal D; Lane JA; Smith GD; Relton C; Eeles RA; Haiman CA; Kote-Jarai Z; Schumacher FR; Olama AAA; Benlloch S; Muir K; Berndt SI; Conti DV; Wiklund F; Chanock SJ; Gapstur S; Stevens VL; Tangen CM; Batra J; Clements JA; Gronberg H; Pashayan N; Schleutker J; Albanes D; Wolk A; West CML; Mucci LA; Cancel-Tassin G; Koutros S; Sorensen KD; Maehle L; Travis RC; Hamilton RJ; Ingles SA; Rosenstein BS; Lu YJ; Giles GG; Kibel AS; Vega A; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; John EM; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva RP; Usmani N; Claessens F; Townsend PA; Dominguez MG; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Martin RM;
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):208-216. PubMed ID: 30352818
[TBL] [Abstract][Full Text] [Related]
13. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study.
Du W; Wang T; Zhang W; Xiao Y; Wang X
Front Genet; 2022; 13():1016696. PubMed ID: 36468030
[No Abstract] [Full Text] [Related]
14. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
Luo J; Dunn T; Ewing C; Sauvageot J; Chen Y; Trent J; Isaacs W
Prostate; 2002 May; 51(3):189-200. PubMed ID: 11967953
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.
Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D
Nutrients; 2023 May; 15(10):. PubMed ID: 37242290
[TBL] [Abstract][Full Text] [Related]
17. Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study.
Liu S; Ding D; Liu F; Guo Y; Xie L; Han FJ
J Ovarian Res; 2024 Jan; 17(1):22. PubMed ID: 38263045
[TBL] [Abstract][Full Text] [Related]
18. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations.
Elbaz EM; Darwish A; Gad AM; Abdel Rahman AAS; Safwat MH
Eur J Pharmacol; 2023 Oct; 957():175993. PubMed ID: 37598927
[TBL] [Abstract][Full Text] [Related]
19. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
20. Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study.
Lin BD; Alkema A; Peters T; Zinkstok J; Libuda L; Hebebrand J; Antel J; Hinney A; Cahn W; Adan R; Luykx JJ
Int J Epidemiol; 2019 Oct; 48(5):1505-1514. PubMed ID: 31504541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
